PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Yale-led study shows ‘significant overall survival benefit’ when lung-cancer drug is taken after surgery

2023-06-07
(Press-News.org) New Haven, Conn. — A clinical trial led by Yale Cancer Center shows that the drug osimertinib, a targeted therapy for non-small cell lung cancer, improved rates of survival and reduced risk of recurrence in patients after surgery.

The results, published June 4 in the New England Journal of Medicine, were presented this week by Dr. Roy Herbst, deputy director of Yale Cancer Center and principal investigator of the ADAURA Phase III clinical trial, during the 2023 annual meeting of the American Society of Clinical Oncology. Herbst is also assistant dean for translational research, ensign professor of medicine (medical oncology), and professor of pharmacology at Yale School of Medicine.

Non-small cell lung cancer (NSCLC), the most common type of lung cancer, tends to recur when diagnosed at advanced stages, which makes treatment challenging.

“ADAURA used osimertinib in the setting of lung cancer where patients already had surgery, and the results are impressive,” said Herbst, who is also chief of medical oncology at Yale Cancer Center. “We’re moving this effective drug therapy into the earliest stages of disease.”

The randomized, double-blind, global Phase III trial assessed the safety and efficacy as well as survival outcomes following osimertinib use in patients with surgically removed EGFR-mutated NSCLC, who were previously treated with or without adjuvant chemotherapy. Trial results showed significant benefits for patients with NSCLC who had taken osimertinib, including prolonged disease-free survival (DFS) over placebo, reduced risk of local and distant metastases (spread of tumor), and improved central nervous system DFS.

In the overall population of patients with stage IB to IIIA disease, the ADAURA study found osimertinib reduced the risk of death by 51%. In all, 88% of patients treated with osimertinib following surgery survived at least five years, compared to 78% of patients treated with a placebo.

“In the U.S., 10 to 15% of patients with lung cancer will have mutations in the epidermal growth factor receptor, and these patients, even after they receive the best available therapy, their tumor still often comes back,” said Herbst. “We’re now adding osimertinib, a pill that targets this specific receptor, and what we’ve found is a significant overall survival benefit for patients who received osimertinib.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Temptation at the checkout: 70% of food, drinks within arm’s reach are unhealthy

Temptation at the checkout: 70% of food, drinks within arm’s reach are unhealthy
2023-06-07
We’ve all been there: waiting in line at a store checkout, surrounded by tempting snacks and drinks. Navigating the checkout lane in search of healthy options could be a challenge, according to researchers at the University of California, Davis, who found that 70% of foods and beverages at checkout are unhealthy. For snack-sized options, an even higher proportion were unhealthy — 89%. A study published this month in the journal Current Developments in Nutrition suggests most food and beverage options at checkout consist of candy (31%), sugar-sweetened beverages (11%), salty snacks (9%) and sweets (6%). Healthy ...

Devastating heart condition can be reversed, study shows for the first time

2023-06-07
Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital.  The condition, a form of amyloidosis affecting the heart, is progressive and has until now been seen as irreversible, with half of patients dying within four years of diagnosis. The new study, published as a letter in The New England Journal of Medicine, reports ...

DNAmFitAge: Biological age indicator incorporating physical fitness

DNAmFitAge: Biological age indicator incorporating physical fitness
2023-06-07
“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.” BUFFALO, NY- June 7, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 10, entitled, “DNAmFitAge: biological age indicator incorporating physical fitness.” Physical fitness is a well-known correlate of health and the aging ...

Now is already too late – The European and international endocrine community calls for immediate action on chemicals legislation is the only way forward to address Endocrine Disrupting Chemicals

2023-06-07
Brussels, Belgium 7 June 2023 – The call for action reverberated across the halls of the European Parliament as a diverse group of scientists, policy makers and interest organisations gathered in a packed room, to discuss how to address the gaps between science and legislation and "Shape an ambitious legislative framework for endocrine disruptors." “Through such meetings with experts, we as policy makers can obtain valuable insight into the latest available science and benefit from it in our legislative ...

Trouble falling asleep, staying asleep linked to increased risk of stroke

2023-06-07
MINNEAPOLIS – People who have insomnia symptoms such as trouble falling asleep, staying asleep and waking up too early, may be more likely to have a stroke, according to a study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. In addition, researchers found the risk was much higher in people under 50 years old. The study does not prove that insomnia symptoms cause stroke; it only shows an association. “There are many therapies that can help people improve the quality of their sleep, so determining which sleep ...

Seizures while driving and why it’s important to diagnose epilepsy ASAP

2023-06-07
MINNEAPOLIS – Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Focal epilepsy accounts for more than half of all cases of epilepsy. People with this form of epilepsy have recurring seizures that affect one half of the brain. “Seizures while driving pose substantial risks for those experiencing them and for others ...

Creating less-allergenic shrimp using pressure and steam

2023-06-07
With the start of summer, many people will be firing up their grills and roasting everything from hot dogs to steaks. Shrimp won’t be on the menu for millions of Americans with seafood allergies, though a method reported in ACS’ Journal of Agricultural and Food Chemistry could change that. The researchers say that reverse-pressure sterilization can produce a less-allergenic shrimp product that, when tested in mice sensitive to the crustaceans, did not cause severe reactions. Some of the most common foods that people are allergic to are dairy products, wheat, peanuts and seafood. The immune system mistakes some proteins from these foods for an intruder and ...

Mechanical engineers lend fresh insight into battery-based desalination technology

Mechanical engineers lend fresh insight into battery-based desalination technology
2023-06-07
CHAMPAIGN, Ill. — To achieve more effective saltwater desalination, mechanical engineers focused on fluid movement rather than new materials in a new study. By adding microchannels to the inside of battery-like electrodes made of Prussian blue – an intense blue pigment often used in art that also has special chemical properties – researchers increased the extent of seawater desalination five times over their non-channeled counterparts to reach salinity levels below the freshwater threshold. The study, led by University of Illinois Urbana-Champaign ...

Alcohol drinking cut in half with diabetes medication

Alcohol drinking cut in half with diabetes medication
2023-06-07
Semaglutide is sold under brand names such as Ozempic. Since this medication was also approved for the treatment of obesity, demand has increased, which has resulted in difficulties in procuring the drug in recent times. There is anecdotal evidence of patients with obesity or diabetes saying that their craving for alcohol has lessened since they started taking the drug. Today, individuals with alcohol dependence are treated with a combination of various psychosocial methods and medications. Four approved medications are available. Since alcohol dependence is a disease with many causes, the efficacy of these medications varies, and so it is important that we develop additional treatment medications. Reduced ...

Detection dog can sniff out highly-endangered great crested newts

Detection dog can sniff out highly-endangered great crested newts
2023-06-07
A trained detection dog was highly accurate at finding great crested newts underground or at a distance, which might aid conservation efforts for this highly-endangered species, according to a study published June 7, 2023 in the open-access journal PLOS ONE by Nicola Jayne Glover from the University of Salford, UK, and colleagues. The highly-endangered great crested newt (Triturus cristatus) is a species of special conservation concern across the UK and central and northern Europe. While much is known about the great crested newts’ aquatic life phase, comparatively little is known about their terrestrial ...

LAST 30 PRESS RELEASES:

Study confirms that people with ADHD can be more creative. The reason may be that they let their mind wander

Research gives insight into effect of neurodegenerative diseases on speech rhythm

Biochar and plants join forces to clean up polluted soils and boost ecosystem recovery

Salk scientist Joseph Ecker awarded McClintock Prize for Plant Genetics and Genome Studies

ADHD: Women are diagnosed five years later than men, despite symptoms appearing at the same age.

Power plants may emit more pollution during government shutdowns

Increasing pressures for conformity de-skilling and demotivating teachers, study warns

Researchers develop smarter menstrual product with potential for wearable health monitoring

Microwaves for energy-efficient chemical reactions

MXene current collectors could reduce size, improve recyclability of Li-ion batteries

Living near toxic sites linked to aggressive breast cancer

New discovery could open door to male birth control

Wirth elected Fellow of American Physical Society

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025

Destined to melt

Attitudes, not income, drive energy savings at home

The playbook for perfect polaritons

‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell

Solar-powered method lights the way to a ‘de-fossilized’ chemical industry

Screen time linked to lower academic achievement among Ontario elementary students

One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study

Enduring outcomes of COVID-19 work absences on the US labor market

Affirmative action repeal and racial and ethnic diversity in us medical school admissions

Cancer progression illuminated by new multi-omics tool

Screen time and standardized academic achievement tests in elementary school

GLP-1RA order fills and out-of-pocket costs by race, ethnicity, and indication

Study finds HEPA purifiers alone may not be enough to reduce viral exposure in schools

UVA Health developing way to ID people at risk of dangerous lung scarring even before symptoms appear

How can we know when curing cancer causes myocarditis?

Male infertility in Indian men linked to lifestyle choices and hormonal imbalances

[Press-News.org] Yale-led study shows ‘significant overall survival benefit’ when lung-cancer drug is taken after surgery